Job Cuts Higher in October; Pharmaceutical & Financial Sectors Took Biggest Hits

06-11-2013 BenzingaComments (0)

Merck & CoPharmaceutical

The Challenger, Gray & Christmas report notes that Merck, like many other pharmaceutical firms, is restructuring its workforce levels “towards drug with the highest potential to win regulatory approval and achieve successful sales levels.” Downsizing ...

Read more on Benzinga

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top